| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69ece09bafee7e0c49d1f7951a3faa2c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6801
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6803 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2021-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b327953af5be3787771cb907c23c4050
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50f71cdb0999aa3dfd7af006c305a4fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6b465101baf7fa6cd74b71a7e7e1913
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ad136a07078158bcea1c0d371783224 |
| publicationDate |
2022-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022020288-A1 |
| titleOfInvention |
Antibody-conjugated chemical inducers of degradation of brm and methods thereof |
| abstract |
The subject matter described herein is directed to antibody-CIDE conjugates (Ab-CIDEs) that target BRM for degradation, to pharmaceutical compositions containing them, and to their use in treating diseases and conditions where BRM degradation is beneficial. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023147329-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023147328-A1 |
| priorityDate |
2020-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |